- Home
- TEVA vs PCG Comparison
TEVA vs PCG Comparison
Compare TEVA & PCG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TEVA | PCG |
|---|---|---|
| Founded | 1901 | 1995 |
| Country | Israel | United States |
| Employees | 32842 | 29000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.1B | 36.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TEVA | PCG |
|---|---|---|
| Price | $30.81 | $17.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $38.63 | $22.19 |
| AVG Volume (30 Days) | 4.3M | ★ 14.8M |
| Earning Date | 04-29-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.22% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.24 |
| Revenue Next Year | $2.97 | $3.41 |
| P/E Ratio | $28.19 | ★ $15.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.99 | $13.32 |
| 52 Week High | $37.35 | $19.16 |
Technical Indicators
Market Signals| Indicator | TEVA | PCG |
|---|---|---|
| Relative Strength Index (RSI) | 40.73 | 60.56 |
| Support Level | $30.59 | $15.47 |
| Resistance Level | $32.74 | $18.94 |
| Average True Range (ATR) | 0.97 | 0.39 |
| MACD | -0.19 | 0.04 |
| Stochastic Oscillator | 23.56 | 81.70 |
Price Performance
Historical ComparisonAbout TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About PCG Pacific Gas & Electric Co.
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.